Biggest News aggregator with 200 million news articles | vimarsana.com
illnesses in america, or conditions, cancer and diabetes in autoimmune diseases. if the drug manufacturers refused to negotiate with medicare, or would agree on a quote, maximum fair price, they will now face a significant tax or be forced to withdraw from medicare and medicaid. medicare's ability to negotiate directly with drug manufacturers is a new power, granted by the inflation reduction act. that landmark law that passed with zero votes from a publicans, who've been trying to dismantle it ever since. joining us now, california congressman, ro khanna, member of the affordable drug pricing task force. congressman, good to see. you got a big smile on your face. about this. this is a simple matter that, to most people, should've been sorted out more than two decades ago. the idea that medicare is allowed to negotiate for the price of the drugs, not free, drugs nobody's getting it free, nobody forcing anybody to sell anything in the government's not taking over the manufacture of anything. this is the right to negotiate because you're a bulk buyer.